Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
startups
deals
life sciences
national blog main
acquisition
azacitidine
bessemer venture partners
beta-thalassemia
boston
boston blog main
boston top stories
carlsmed
dacogen
decitabine
diabetes
diabetes type 2
dna
epigenetics
epizyme
evonexus
farydak
flagship pioneering
fractyl labs
fulcrum therapeutics
funding
fundings & exits
general catalyst
google ventures
gv
health
ido fund
incubator
insulated genomic domains
intuitivex
jeffrey roh
justin esterberg
kaleido biosciences
m&a
mahesh karande
What
based
3
×
developing
3
×
startup
3
×
medical
aims
approach
associates
bessemer
biotech
called
capital
carlsmed
catalyst
company
debuts
deerfield
develop
diabetes
diego
domain
drugs
emergent
epigenetic
epigenetics
field
financing
firms
flagship’s
fractyl
fund
general
gv
ido
imaging
implants
including
l.p
labs
lexington
management
Language
unknown
unset
Current search:
developing
×
startup
×
biotech
×
based
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company
@techcrunch.com
6 years ago
Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes
